Yaoyu Guo1,2, Bang Hu1,2, Dandan Huang1,2, Xinhua Wang1,2, Juan Li1,2, Di Zhang1,2, Xueying Li3, Gong Chen4, Donglin Ren5,6. 1. The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Tianhe District, Guangzhou, 510655, People's Republic of China. 2. Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, 26 Yuancun Erheng Road, Tianhe District, Guangzhou, 510655, People's Republic of China. 3. Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, 651 Dongfeng East Road, Yuexiu District, Guangzhou, 510080, People's Republic of China. 4. Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, 651 Dongfeng East Road, Yuexiu District, Guangzhou, 510080, People's Republic of China. chengong@sysucc.org.cn. 5. The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Tianhe District, Guangzhou, 510655, People's Republic of China. rendl111@163.com. 6. Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, 26 Yuancun Erheng Road, Tianhe District, Guangzhou, 510655, People's Republic of China. rendl111@163.com.
Abstract
BACKGROUND: Perianal/perineal rhabdomyosarcomas (PRMS) are easily misdiagnosed soft tissue tumours with a poor prognosis. This study was designed to analyze the clinical, diagnostic, pathological and prognostic features of PRMS, and to explore currently available therapeutic modalities. METHODS: Clinical data of PRMS patients admitted to the Sixth Affiliated Hospital and the Cancer Center of Sun Yat-sen University and from related Chinese literature published from 1987 to 2018 were collected and analyzed. The Chi-square test was used to evaluate the differences between each group. The Kaplan-Meier methods were applied to estimate and compare survival rates. RESULTS: A total of 35 patients were included in this study; 20 identified within related Chinese literatures and 15 from our center admitted during the period of 1997-2019. Out of these cases, 34 presented with perianal masses and the remaining one manifested as an inguinal mass. Moreover, 20 patients complained of pain and 16 of them were misdiagnosed as perianal abscesses, in which the presence of pain contributed to the misdiagnosis (p < 0.05). The average time interval between symptom onset and pathological diagnosis was 3.1 months. Next, 13 cases were classified into IRS group III/IV and 20 cases into stages 3/4. Additionally, 14 and 9 cases received the pathological diagnoses of embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma, respectively. Regarding the patients' survival rates, five patients survived for more than 2 years, and three of them survived for more than 5 years. The overall 2 years and 5 years survival rates were 32% and 24%, respectively. The symptom of pain and misdiagnosis both contributed to the poor prognosis in these patients (p < 0.05). MRI showed that the PRMS were closely related to external anal sphincter in 10 cases. CONCLUSION: PRMS are easily misdiagnosed lesions, which often leads to an unfavourable outcome in affected patients. Patients with painful perianal masses should be evaluated to exclude PRMS. MRI revealed that PRMS are closely related to the external anal sphincter. Multidisciplinary management is recommended in the treatment of PRMS.
BACKGROUND: Perianal/perineal rhabdomyosarcomas (PRMS) are easily misdiagnosed soft tissue tumours with a poor prognosis. This study was designed to analyze the clinical, diagnostic, pathological and prognostic features of PRMS, and to explore currently available therapeutic modalities. METHODS: Clinical data of PRMS patients admitted to the Sixth Affiliated Hospital and the Cancer Center of Sun Yat-sen University and from related Chinese literature published from 1987 to 2018 were collected and analyzed. The Chi-square test was used to evaluate the differences between each group. The Kaplan-Meier methods were applied to estimate and compare survival rates. RESULTS: A total of 35 patients were included in this study; 20 identified within related Chinese literatures and 15 from our center admitted during the period of 1997-2019. Out of these cases, 34 presented with perianal masses and the remaining one manifested as an inguinal mass. Moreover, 20 patients complained of pain and 16 of them were misdiagnosed as perianal abscesses, in which the presence of pain contributed to the misdiagnosis (p < 0.05). The average time interval between symptom onset and pathological diagnosis was 3.1 months. Next, 13 cases were classified into IRS group III/IV and 20 cases into stages 3/4. Additionally, 14 and 9 cases received the pathological diagnoses of embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma, respectively. Regarding the patients' survival rates, five patients survived for more than 2 years, and three of them survived for more than 5 years. The overall 2 years and 5 years survival rates were 32% and 24%, respectively. The symptom of pain and misdiagnosis both contributed to the poor prognosis in these patients (p < 0.05). MRI showed that the PRMS were closely related to external anal sphincter in 10 cases. CONCLUSION: PRMS are easily misdiagnosed lesions, which often leads to an unfavourable outcome in affected patients. Patients with painful perianal masses should be evaluated to exclude PRMS. MRI revealed that PRMS are closely related to the external anal sphincter. Multidisciplinary management is recommended in the treatment of PRMS.
Authors: D Ashley Hill; Louis P Dehner; Kenneth W Gow; Alberto S Pappo; David Crawford; Sean M Pflaumer; Wayne L Furman; Andrea A Hayes-Jordan; Michael B McDermott Journal: J Pediatr Surg Date: 2002-04 Impact factor: 2.545
Authors: Iyad Sultan; Ibrahim Qaddoumi; Sameer Yaser; Carlos Rodriguez-Galindo; Andrea Ferrari Journal: J Clin Oncol Date: 2009-04-27 Impact factor: 44.544
Authors: Dana L Casey; Leonard H Wexler; Michael P LaQuaglia; Paul A Meyers; Suzanne L Wolden Journal: Int J Radiat Oncol Biol Phys Date: 2014-05-01 Impact factor: 7.038
Authors: Emily R Christison-Lagay; Jason F Hall; Paul W Wales; Karen Bailey; Andrew Terluk; Allan M Goldstein; Sigmund H Ein; Peter T Masiakos Journal: Pediatrics Date: 2007-08-06 Impact factor: 7.124
Authors: W Crist; E A Gehan; A H Ragab; P S Dickman; S S Donaldson; C Fryer; D Hammond; D M Hays; J Herrmann; R Heyn Journal: J Clin Oncol Date: 1995-03 Impact factor: 44.544